Schedule 13G ownership disclosure

Anacor Pharmaceuticals Inc

Security class unavailable · CUSIP: 032420101

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,521,822
Percent of class
5.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-15-000005
Form type
SC 13G
Filer
Anacor Pharmaceuticals, Inc.
CIK
CIK 1411158
Filed
Feb 18, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub